Clinical trials
Squamous Cell Carcinoma of Head and Neck trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
109 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 11 |
| 2021 | 12 |
| 2022 | 7 |
| 2023 | 12 |
| 2024 | 16 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 29 |
| Completed | 28 |
| Terminated | 25 |
| Active, not recruiting | 20 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MacroGenics | 6 |
| Merck Sharp & Dohme LLC | 5 |
| AbbVie | 4 |
| Amgen | 4 |
| AstraZeneca | 4 |
| GlaxoSmithKline | 4 |
| Pfizer | 4 |
| BeiGene | 3 |
| Novartis Pharmaceuticals | 3 |
| ALX Oncology Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 109 |
| Carcinoma, Non-Small-Cell Lung | 43 |
| Melanoma | 30 |
| Colorectal Neoplasms | 24 |
| Head and Neck Neoplasms | 23 |
| Triple Negative Breast Neoplasms | 22 |
| Uterine Cervical Neoplasms | 21 |
| Carcinoma, Renal Cell | 20 |
| Neoplasm Metastasis | 19 |
| Ovarian Neoplasms | 18 |
Trials
Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.
9 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.